Site icon OncologyTube

Cases When Cell Free DNA is Most Beneficial – Specific patient populations and stage of disease

Jens Lohr, MD from Dana-Farber Cancer Institute discusses cases when cell free DNA is most beneficial and specific patient populations and stage of disease at the 2017 American Society of Hematology.

Exit mobile version